Login / Signup

SLy2-overexpression impairs B-cell development in the bone marrow and the IgG response towards pneumococcal conjugate-vaccine.

Jennifer JaufmannLeyla TümenSandra Beer-Hammer
Published in: Immunity, inflammation and disease (2021)
Our findings demonstrate an important role of the adapter protein SLy2 in the context of adaptive antibody responses against pneumococcal conjugate-vaccine. Interestingly, deficits in humoral immunity seemed to be compensated by cellular immune effectors upon bacterial challenge. Our study further shows a novel relevance of SLy2 for plasmablasts and B-cell progenitors in the BM.
Keyphrases
  • bone marrow
  • immune response
  • cancer therapy
  • mesenchymal stem cells
  • transcription factor
  • protein protein
  • small molecule